Sunitinib malate
| Sunitinib malate | |
|---|---|
| Term | Sunitinib malate |
| Short definition | Sunitinib malate - (pronounced) (soo-NIH-tih-nib MA-layt) drug used to treat adults with certain types of gastrointestinal stromal tumors, neuroendocrine tumors of the pancreas, or renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Sunitinib malate - (pronounced) (soo-NIH-tih-nib MA-layt) drug used to treat adults with certain types of gastrointestinal stromal tumors, neuroendocrine tumors of the pancreas, or renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Sunitinib malate blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Sunitinib malate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis drug. Sunitinib is the active ingredient in sunitinib malate. Also called SU011248, SU11248 and Sutent
External links
- Medical encyclopedia article on Sunitinib malate
- Wikipedia's article - Sunitinib malate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski